How could the glyphosate safety review affect the EPA Administrator's regulatory authority?
The EPA Administrator must navigate scientific findings and legal rulings on glyphosate. The Administrator of the Environmental Protection Agency is currently overseeing a comprehensive review of glyphosate's human health effects, which was initiated after a court decision found fault with the agency’s previous 2020 assessment. The Administrator has stated that staff are empowered to follow the science fully and transparently communicate the findings. This review is complicated by the Supreme Court's ruling that federal pesticide law preempts state 'failure-to-warn' claims, meaning the Administrator must ensure the final EPA-approved label meets federal standards while addressing scientific concerns, such as the International Agency for Research on Cancer classifying Roundup as a probable human carcinogen.
- Effect
- Mixed
- How direct
- Stated in the reporting
- When
- Within weeks
- The story
- Gone quiet
How it reaches Administrator of the Environmental Protection Agency
-
The Supreme Court ruled that federal pesticide law preempts state lawsuits that allege a failure to warn of pesticide dangers, such as cancer risks posed by glyphosate. This ruling was applied in a case involving Monsanto and Bayer. Separately, a Missouri jury issued a verdict in favor of Monsanto in a Roundup liability trial.
The full event5independent outlets -
The ongoing litigation and scientific scrutiny of glyphosate, including the International Agency for Research on Cancer classifying Roundup as a probable human carcinogen, requires the Environmental Protection Agency to reassess its risk assessment. This review was prompted after the agency's 2020 interim decision was vacated by the 9th U.S. Circuit Court of Appeals in June 2022. As the Administrator, the agency head must direct staff to review the science fully, as stated by Lee Zeldin. Furthermore, the Administrator must ensure that any resulting pesticide labels comply with the Federal Insecticide Fungicide and Rodenticide Act, which the Supreme Court affirmed preempts state 'failure-to-warn' requirements.
2 reports connect these two. Brind only summarizes; follow a link to read the reporting itself.
- tsln.com Nov 13
- agri-pulse.com May 28
-
federal governmental agency within the United States
Everything about Administrator of the Environmental Protection Agency
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- IARC classified Roundup chemical while EPA assessed glyphosate risktsln.com
- Supreme Court affirmed EPA label requirements and reviewed Monsanto lawsuitcapitalpress.com
- EPA Administrator Lee Zeldin says staff reviewing the safety of glyphosate will follow the scienceagri-pulse.com
- EPA withdrew the human health portion of its 2020 interim decision after that section was vacated by the 9th U.S. Circuit Court of Appeals in June 2022agri-pulse.com
Why it matters
The Administrator's decisions carry significant weight for the agricultural industry and public health. If the review leads to new restrictions or label changes, it could impact the use of glyphosate, which is described as the world’s most widely used weedkiller. Conversely, if the Administrator maintains the current regulatory stance, it supports the position of farming groups who argue that restricting glyphosate would severely reduce crop production and lead to higher grocery prices.
This regulatory battle is set against a backdrop of intense political pressure. The Trump administration has provided political and legal support to Bayer in its appeal to the Supreme Court. This political alignment contrasts with the concerns of health advocates who are critical of farm pesticides, highlighting the complex intersection of science, corporate interests, and political ideology in setting national environmental policy.
What we don't know yet
- What specific scientific findings will the EPA staff reach regarding glyphosate's human health effects?
- How will the Administrator reconcile the Supreme Court's preemption ruling with scientific findings suggesting increased cancer risk?
Is this still moving?
- Reports
- 5
- Developments
- 7
- Repetition
- 20%
What would change this answer
Who else could feel it
Other possible ripples from the same event.
Reporting
- tsln.comNov 13
- agri-pulse.comMay 28
- abc.net.auAug 5
- capitalpress.comJun 25
- washingtonexaminer.comMay 26
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.